Patients carrying LAPTM4B*2 allele indicated 1.176-fold higher risk of developing breast cancer than those carrying LAPTM4B*1 (P<0.001, OR = 1.176, 95%CI = 1.082–1.278) (Table 1). The gene discussed is LAPTM4B; the disease is breast carcinoma.